Help | Scores |Exit
Fragmin | Magnex | Solu Medrol
Atenolol Drug Name:  
A|B|C|D|E|F|G|H|I|K|L|M|N|O|P|Q|R|S|T|V|Z
Quick Dosage
Indications
Dosages
Interactions
Precautions
Contraindications
Adverse Reactions
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interactions:

Acarbose

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Adrenaline

  • Adverse Effect: Hypertension, bradycardia, resistance to Adrenaline in anaphylaxis
  • Clinical Management: Concurrent use should be avoided if possible. However, if used concurrently, monitor blood pressure carefully. If a nonselective Atenolol causes resistance to Adrenaline in anaphylactic shock, glucagon may be effective in a dose of 1 mg or more intravenously every five minutes.

    Amiodarone

  • Adverse Effect: hypotension, bradycardia, or cardiac arrest
  • Clinical Management: Monitor cardiac function carefully. Amiodarone should be used with caution in patients receiving beta blockers particularly if there is suspicion of underlying dysfunction of the sinus node, such as bradycardia or sick sinus syndrome, or if there is partial AV block.

    Amlodipine

  • Adverse Effect: Hypotension and/or bradycardia
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Ampicillin

  • Adverse Effect: decreased atenolol effectiveness
  • Clinical Management: If used concurrently, monitor blood pressure and adjust atenolol dose if necessary.

    Antacids Comb.

  • Adverse Effect: reduced effectiveness of atenolol
  • Clinical Management: Instruct patients to not take atenolol and antacids at the same time. Atenolol should be administered two hours before or six hours after the antacid.

    Celecoxib

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Chlorpropamide

  • Adverse Effect: Hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Clonidine

  • Adverse Effect: exaggerated clonidine withdrawal response (acute hypertension)
  • Clinical Management: When clonidine is to be withdrawn from concomitant therapy with a beta blocker, discontinue the beta blocker first, and monitor blood pressure carefully. Labetalol (alph/beta blocker) or alpha blockers (eg, prazosin, doxazosin) may prevent rebound hypertension.

    Diclofenac Preps.

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Digoxin

  • Adverse Effect: AV block and possible digoxin toxicity
  • Clinical Management: When beta blockers and digoxin are to be given concomitantly, carefully monitor ECG and digoxin serum concentrations. Adjust doses accordingly.

    Diltiazem

  • Adverse Effect: hypotension, bradycardia, AV conduction disturbances
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure. A dosage adjustment for hepatically metabolized beta blockers may be required.

    Disopyramide

  • Adverse Effect: Bradycardia, decreased cardiac output
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients with pre-existing heart disease.

    Doxazosin

  • Adverse Effect: an exaggerated hypotensive response to the first dose of the alpha blocker
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Felodipine

  • Adverse Effect: Hypotension and/or bradycardia
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Flunarizine

  • Adverse Effect: hypotension, bradycardia, and AV conduction disturbances
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure or bradyarrhythmias.

    Flurbiprofen

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Glibenclamide

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects.Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Gliclazide

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Glimepiride

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Glipizide

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Guar Gum

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Ibuprofen

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Indomethacin

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Insulin Lispro

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Ketoprofen

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Ketorolac

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Lacidipine

  • Adverse Effect: Hypotension and/or bradycardia
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Lidoflazine

  • Adverse Effect: hypotension, bradycardia, and AV conduction disturbances
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure or bradyarrhythmias.

    Mefenamic Acid

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Meloxicam

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Metformin

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Methyldopa

  • Adverse Effect: exaggerated hypertensive response, tachycardia, or arrhythmias during physiologic stress or exposure to exogenous catecholamines
  • Clinical Management: Monitor blood pressure carefully during concurrent therapy, especially during excessive physiologic stress or use of exogenous catecholamines such as phenylpropanolamine.

    Nabumetone

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Naproxen

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Nifedipine

  • Adverse Effect: Hypotension and/or bradycardia
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Nimesulide

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Nimodipine

  • Adverse Effect: hypotension and/or bradycardia
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Nitrendipine

  • Adverse Effect: Hypotension and/or bradycardia
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.

    Oxyphenbutazone

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Paracetamol

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Phenacetin

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Phenylbutazone

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Piroxicam

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Prazosin

  • Adverse Effect: an exaggerated hypotensive response to the first dose of the alpha blocker
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Prazosin - BPH

  • Adverse Effect: an exaggerated hypotensive response to the first dose of the alpha blocker
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Procainamide

  • Adverse Effect: Increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest)
  • Clinical Management: The concurrent administration of Atenolol is not recommended. The Atenolol should be withheld for at least three half-lives prior to dosing.

    Quinidine

  • Adverse Effect: Bradycardia, hypotension
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully (ie, blood pressure, heart rate). It may be necessary to lower the initial dose of each drug.

    Ritodrine

  • Adverse Effect: potential interference with tocolytic action of ritodrine
  • Clinical Management: It is possible to successfully treat a patient with both a beta blocker and a beta mimetic if an appropriate dosage is found and the clinical response is monitored.

    Tenoxicam

  • Adverse Effect: Decreased antihypertensive effect
  • Clinical Management: If concurrent therapy is required, monitor the patients blood pressure carefully and assess the need for a dosage adjustment for the beta blocker.

    Terazosin

  • Adverse Effect: an exaggerated hypotensive response to the first dose of the alpha blocker
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Terazosin - BPH

  • Adverse Effect: an exaggerated hypotensive response to the first dose of the alpha blocker
  • Clinical Management: When concurrent therapy with an alpha blocker and a beta blocker is required, initiate the alpha blocker with a smaller than usual dose, preferably at bedtime. Monitor the patient closely for hypotension.

    Tolbutamide

  • Adverse Effect: hypoglycemia, hyperglycemia, or hypertension
  • Clinical Management: If the use of a beta blocker is required in a diabetic, watch for decreased diabetic control by monitoring the patients glucose carefully. Cardioselective beta blockers (atenolol, metoprolol) cause less disturbance of glucose metabolism and less masking of hypoglycemic effects. Propranolol accounts for the majority of positive reports of an interaction and should clearly be avoided.

    Verapamil

  • Adverse Effect: hypotension, bradycardia
  • Clinical Management: If concurrent therapy is required, monitor cardiac function carefully, particularly in patients predisposed to heart failure.
  • Acetaminophen
    Adenosine
    AlbuterolSulfate
    Allopurinol
    Alprostadil
    AmantadineHydrochloride
    AmikacinSulfate
    Aminophylline
    Amoxicillin
    AmoxicillinTrihydrate
    Amphotericin B
    Amphotericin B Cholesteryl Sulfate Complex
    Ampicillin
    Ampicillin Sodium
    Ascorbic Acid (Vitamin C)
    Aspirin
    Atropine Sulfate
    Azelastine Hydrochloride
    Aztreonam
    Abciximab
    Acenocoumarol
    Acarbose
    Acetazolamide
    Acetazolamide - Ocular
    Acyclovir
    Acyclovir - Ocular
    Acyclovir-AV
    Adapalene
    Adrenaline
    Adrenaline - Inh
    Adrenaline - resp
    Adrenochrome
    Albendazole
    Aldosterone
    Alendronate
    Alprazolam
    Amantadine-AV
    Amifostine
    Amikacin
    Amiloride
    Aminocaproic Acid
    Amiodarone
    Amitriptyline
    Amlodipine
    Amodiaquine
    Amoxapine
    Amrinone
    Analgin
    Aprotinin
    Ardeparin
    Arteether
    Artemether
    Artesunate
    Aspartame
    Astemizole
    Atenolol
    Atorvastatin
    Atracurium
    Auranofin ( Gold )
    Azatadine
    Azathioprine
    Azithromycin
     
    Disclaimer